Growing community of inventors

Berlin, Germany

Thomas Zollner

Average Co-Inventor Count = 4.80

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Thomas ZollnerHartmut Rehwinkel (3 patents)Thomas ZollnerMarkus Berger (3 patents)Thomas ZollnerHeike Schaecke (1 patent)Thomas ZollnerHeike Schäcke (5 patents)Thomas ZollnerJorma Hassfeld (3 patents)Thomas ZollnerEkkehard May (2 patents)Thomas ZollnerMichaele Peters (1 patent)Thomas ZollnerMarkus Koch (1 patent)Thomas ZollnerBkkehard May (1 patent)Thomas ZollnerThomas Zollner (4 patents)Hartmut RehwinkelHartmut Rehwinkel (53 patents)Markus BergerMarkus Berger (37 patents)Heike SchaeckeHeike Schaecke (16 patents)Heike SchäckeHeike Schäcke (5 patents)Jorma HassfeldJorma Hassfeld (5 patents)Ekkehard MayEkkehard May (2 patents)Michaele PetersMichaele Peters (3 patents)Markus KochMarkus Koch (3 patents)Bkkehard MayBkkehard May (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bayer Pharma Aktiengesellschaft (2 from 378 patents)

2. Astrazeneca Ab (1 from 1,500 patents)

3. Bayer Intellectual Property Gmbh (1 from 721 patents)

4. Bayer Schering Pharma Ag (1 from 192 patents)


4 patents:

1. 11266646 - Use of chymase inhibitors for the treatment of endometriosis, post operative fibrosis and diseases which are characterized by fibrosis formation

2. RE47047 - 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

3. 8680117 - [object Object]

4. 8394958 - 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…